Table 3 Description of participants with type 1 diabetes negative for diabetes-associated autoantibodies (GADA, IA-2A, IAA and ZnT8A).
Participant number | Sex | Age (years) | Ketonuria | Ketoacidosis | Weight loss | Random C-peptide (nmol/l) | HbA1c (mmol/mol) | HbA1c (%) | BMI (kg/m2) | Concomitant autoimmune diseases | Family history of T1D | PTPN22 rs2476601 | CTLA CT60 rs3087243 | SLC30A8 rs13266634 | IFIH1 rs1990760 | HLA haplotypes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | M | 33.0 | – | – | + | 0.12 | 139 | 14.9 | 19.6 | – | + | CT | AG | CC | GA | (DR3)-DQA1*05-DQB1*02 and (DR3)-DQA1*05-DQB1*02 |
2 | M | 39.4 | + | – | + | 0.35 | 87 | 10.1 | 19.6 | – | – | CC | AG | TT | GA | DRB1*0401-DQA1* 03-DQB1*0302 and (DR13)-DQB1*0604 |
3 | M | 26.6 | + | – | + | 0.10 | 117 | 12.9 | 21.5 | – | – | CC | GG | TT | GA | (DR1/10)-DQB1*0501 and (DR8)-DQB1*04 |
4 | M | 58.3 | + | – | + | 0.27 | 115 | 12.7 | 24.3 | – | + | CC | AA | CC | AA | (DR3)-DQA1*05- DQB1*02 and DRB1*0401-DQA1* 03-DQB1*0302 |
5 | M | 41.8 | + | + | + | NA | 121 | 13.2 | 38.2 | – | – | CC | GG | CC | GG | (DR16)-DQB1*0502 and (DR15)-DQB1* 0602 |
6 | M | 42.9 | + | + | + | 0.10 | 138 | 14.8 | 23.5 | – | – | CC | GG | CT | GG | (DR11/12/13)-DQA1* 05-DQB1*0301 and (DR15)-DQB1*0602 |